- Accesswire•5 days ago
BEND, OR / ACCESSWIRE / February 21, 2017 / RepliCel (OTCQB: REPCF) (TSX-V: RP.V) advances in regenerative medicine. Source: RepliCel Throughout nature, many animal species have the ability to regenerate ...
- PR Newswire•17 days ago
RCI-02, RepliCel's nearest-term commercial asset, enables game-changing reliability, reproducibility, and programmability of three-dimensional skin injections VANCOUVER, Feb. 9, 2017 /PRNewswire/ - RepliCel ...
- CNW Group•17 days ago
RepliCel Announces European Patents for its Innovative Dermal Injector Technologies
REPCF : Summary for REPLICEL LIFE SCI COM NPV(POST - Yahoo Finance
RepliCel Life Sciences Inc. (REPCF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.68 - 0.89|
|52 Week Range||0.43 - 1.46|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.68|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|